CSE:BEV

BevCanna Further Strengthens CPG Expertise with the Addition of Former Colgate and Unilever Executives to the Team

The appointment of Raffael Kapusty and Bill Niarchos to sales leadership roles will accelerate the Company's CPG expansion

Diversified health and wellness, beverage and natural products company, BevCanna Enterprises Inc. ( CSE:BEV, Q:BVNNF , FSE:7BC ) (" BevCanna " or the " Company ") announced today that it has added two veteran CPG senior sales leaders to the organization. Raffael Kapusty will join the company as Vice-president of Sales and Insights and Bill Niarchos will hold the role of Vice-president of Sales and Sales Operations.

Ms. Kapusty and Mr. Niarchos will play a critical role in the BevCanna's transformation into a diversified beverage and natural products company, working in tandem to lead the Company's domestic and international sales execution and scale the points of distribution. Priorities will include further bolstering BevCanna's white-label clientele and expanding its international CPG distribution network of Canadian and U.S. big box retailers.

"We are very excited about Raffael and Bill joining the team and further strengthening our CPG expertise," said Melise Panetta, President of BevCanna. "As we continue our transformation into a diversified beverage and natural products company, we're adding capabilities in a number of key areas, and Raffael's and Bill's extensive experience across the North American retail sector will be invaluable to us as we move ahead with our expansion strategies."

About Raffael Kapusty

Raffael Kapusty is an accomplished CPG industry leader with more than 25 years of experience in both the Canadian and U.S. retail spaces. Most recently, Raffael led sales and marketing at Ice Age Glacial Water Company, successfully growing points of distribution in the natural products sector and expanding into mainstream grocery.

Prior to Ice Age Glacial, Raffael held a number of progressively senior sales and insight roles at Lassonde, a North American leader in the sale of fruit and vegetable juices. As a ‘Fact Based' seller, connecting category, consumer and customer, she developed and executed profitable customer solutions aligned with retail strategies, and was successful in growing both branded and in-house portfolios.

With a solid foundation at ACNielsen Canada ( NYSE:NLSN ), Raffael has developed a deep understanding of the CPG space, working with over 100 leading Canadian & global CPG manufacturers. She has also held senior category and key account management roles at Kruger ( NYSE:KR ), SC Johnson and Unilever Canada ( NYSE:UL ).

About Bill Niarchos

Bill Niarchos has over 20 years of experience in the CPG goods industry/retail environment. In his most recent role as Director of Sales with Bayer Consumer Health, Bill managed the strategic direction and growth of Loblaw & SDM.

Prior to his position with Bayer ( ETR:BAYN ), Bill held a number of progressive roles at Colgate Palmolive ( NYSE:CL ) for more than 14 years. Bill is experienced in managing trade channels in various capacities, including as National Account Manager - Walmart ( NYSE:WMT ) and Costco ( NASDAQ:COST ), Director of Sales - Drug Channel, Director Customer Development - Mass and Club and Director of Customer Development - Loblaw Companies Limited ( TSX:L ) (including SDM).

Previous to his tenure at Colgate Palmolive Bill worked with The Great Atlantic and Pacific Company (Dominion and Food Basics) as a Category Manager. He managed total revenues, net and gross profits for all in-aisle, and seasonal programs for a number of grocery categories. Bill was also employed by Loblaw Companies Limited where he gained the knowledge, experience and infrastructure in relation to the retail environment.

About BevCanna Enterprises Inc.

BevCanna Enterprises Inc. ( CSE:BEV, Q:BVNNF , FSE:7BC ) is a diversified health & wellness beverage and natural products company. BevCanna develops and manufactures a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients.

With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna's extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S. cannabis beverage company Keef Brands .

On behalf of the Board of Directors:
John Campbell, Chief Financial Officer and Chief Strategy Officer
Director, BevCanna Enterprises Inc.

Disclaimer for Forward-Looking Information

This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: the new executives will accelerate the Company's CPG expansion and will play a critical role in the BevCanna's transformation into a diversified beverage and natural products company; that their priorities will include further bolstering BevCanna's white-label clientele and expanding its international CPG distribution network of Canadian and U.S. big box retailers; that their extensive experience across the North American retail sector will be invaluable to the Company as it moves ahead with its expansion strategies; the intended use of the net proceeds of the Placement; and other statements regarding the business plans of the Company. The forward-looking statements reflect management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements.

Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include, among other things: general market conditions; changes to consumer preferences; and volatility of commodity prices; and other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

The Company also announces that it has published an updated corporate presentation that may be viewed at: https://bevcanna.s3.us-east-2.amazonaws.com/BevCanna+Corporate+Presentation-Final.pdf .

The Company also announces that is has closed a non-brokered private placement (the "Placement") consisting of the issuance of 100,000 common shares (each, a "Share") of the Company at a price of $1.00 per Share for gross proceeds of $100,000. The Company intends to use the net proceeds of the Placement for general working capital purposes. The securities issued in the Placement are subject to resale restrictions imposed by applicable law or regulation, including a statutory hold period expiring four months and one day from the date of closing of the Placement. No finder's fees were paid in connection with the Placement.

None of the securities issued in the Placement will be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This news release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

For media enquiries or interviews, please contact:
Wynn Theriault, Thirty Dash Communications Inc.
416-710-3370
wynn@thirtydash.ca

For investor enquiries, please contact:
Bryce Allen, BevCanna Enterprises Inc.
778-766-3744
bryce@bevcanna.com

News Provided by Business Wire via QuoteMedia

The Conversation (0)
A hand holding a cannabis leaf in front of the US flag.

Cannabis Round-Up: US DEA Proposes Rescheduling, Canada Ignores Company Tax Concerns

April was a game-changer for the cannabis industry.

After deliberating for almost five months, the Drug Enforcement Administration moved to reschedule cannabis as lawmakers worked to combine the SAFER Banking Act with newly introduced stablecoin legislation.

Meanwhile, controversy struck as legal cannabis was seized in New Mexico, Canada's Federal Budget 2024 was released with no mention of reform to high excise tax rates, and the saga of a once high-end cannabis dispensary finally ended in bankruptcy.

Keep reading...Show less

Goodness Growth Holdings Announces Filing of Application for Summary Determination in Litigation with Verano

Filing reflects Company's belief that Verano's defense against claims of unlawful conduct is without merit –

– Legal filing represents a documentary record and corresponding damages analysis –

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Court gavel in front of national flag of the USA having shadows of cannabis on wooden table.

DEA Submits Proposal to Reschedule Cannabis, Stocks Rally

The Associated Press reported Tuesday (April 30) that the US Drug Enforcement Administration (DEA) was on the cusp of rescheduling cannabis from a Schedule I substance, the same category as heroin and methamphetamines, to Schedule III.

The Department of Health and Human Services suggested cannabis be reclassified on August 29, 2023, and the DEA has been deliberating on the decision for months, urged by lawmakers to heed the recommendation.

According to the report, Attorney General Merrick Garland was scheduled to submit the proposal to the White House Office of Management and Budget on Tuesday afternoon. President Biden has been vocal about his stance on this issue and has urged the Attorney General to expedite the process, suggesting his readiness to move forward once the proposal reaches his desk.

Keep reading...Show less

Goodness Growth Provides CREAM & Fire Updates

Josh Rosen to shed Interim title and become Chief Executive Officer; Company provides other key personnel updates –

– Company receives a short-term extension of the maturity date on its credit facility –

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Goodness Growth Holdings to Release First Quarter 2024 Results on May 7, 2024

Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers, today announced that it will release its financial results for its first quarter ended March 31, 2024 on Tuesday, May 7, 2024 after the market closes.

Goodness Growth management will host a conference call with the investment community that day, Tuesday, May 7, 2024 at 4:30 p.m. ET (3:30 p.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-800-715-9871 (Toll-Free) (US and Canada) or 1-646-307-1963 (Toll) (International) and referencing conference ID number 3718174.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20, 2024, at 11:00 a.m. ET.

Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the 2024 Annual Meeting online regardless of their geographic location, including a chance to ask questions and vote.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×